Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

Washington, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy research organization as Director of Research. In this role, he will oversee NPC’s research portfolio focusing on individual patient and population health outcomes, understanding differences in patients and treatment effects and health care access issues.

“Michael will be a valuable addition to NPC’s research efforts, and he comes at an important time as we continue to explore new issues and challenges facing patients and the pharmaceutical industry,” said Dan Leonard, NPC president.

Mr. Ciarametaro has 13 years of health care industry experience with both pharmaceutical manufacturers and payers. Most recently, he was a senior research manager at Evidera, where he designed and led a wide variety of both qualitative and quantitative studies across multiple health care industries and stakeholders.  Ciarametaro’s work analyzed reimbursement and treatment patterns for drugs, biologics and devices. Prior to Evidera, he served as a financial analysis manager at WellPoint NextRx and as lead staff at Noblis, a nonprofit science, technology and strategy organization.

He also has presented his work at numerous high-profile research conferences, including annual meetings hosted by the Academy of Managed Care Pharmacy and the International Society for Pharmacoeconomics and Outcomes Research.

Mr. Ciarametaro holds a Bachelor of Science from the University of Virginia and received his MBA from George Mason University.

“I am excited that Michael has joined our staff. At NPC we’re focused on educating and informing the public, policymakers and opinion leaders about the critical issues of evidence, innovation and the value of medicines for patients,” said NPC Chief Science Officer Robert W. Dubois, MD, PhD. “Michael’s experience and expertise in value-based determinations, reimbursement and formulary decisions will be a strong complement to our ongoing research efforts.”

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

# # #